BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 20620061)

  • 1. Fukutin mutations in congenital muscular dystrophies with defective glycosylation of dystroglycan in Korea.
    Lim BC; Ki CS; Kim JW; Cho A; Kim MJ; Hwang H; Kim KJ; Hwang YS; Park WY; Lim YJ; Kim IO; Lee JS; Chae JH
    Neuromuscul Disord; 2010 Aug; 20(8):524-30. PubMed ID: 20620061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fukuyama congenital muscular dystrophy and related alpha-dystroglycanopathies].
    Murakami T; Nishino I
    Brain Nerve; 2008 Oct; 60(10):1159-64. PubMed ID: 18975603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan.
    Longman C; Brockington M; Torelli S; Jimenez-Mallebrera C; Kennedy C; Khalil N; Feng L; Saran RK; Voit T; Merlini L; Sewry CA; Brown SC; Muntoni F
    Hum Mol Genet; 2003 Nov; 12(21):2853-61. PubMed ID: 12966029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital muscular dystrophy with glycosylation defects of alpha-dystroglycan in Japan.
    Matsumoto H; Hayashi YK; Kim DS; Ogawa M; Murakami T; Noguchi S; Nonaka I; Nakazawa T; Matsuo T; Futagami S; Campbell KP; Nishino I
    Neuromuscul Disord; 2005 May; 15(5):342-8. PubMed ID: 15833426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and genetic analysis of a Korean patient with Fukuyama congenital muscular dystrophy.
    Lee J; Lee BL; Lee M; Kim JH; Kim JW; Ki CS
    J Neurol Sci; 2009 Jun; 281(1-2):122-4. PubMed ID: 19324374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New POMT2 mutations causing congenital muscular dystrophy: identification of a founder mutation.
    Yanagisawa A; Bouchet C; Van den Bergh PY; Cuisset JM; Viollet L; Leturcq F; Romero NB; Quijano-Roy S; Fardeau M; Seta N; Guicheney P
    Neurology; 2007 Sep; 69(12):1254-60. PubMed ID: 17634419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and etiology of congenital muscular dystrophy.
    Peat RA; Smith JM; Compton AG; Baker NL; Pace RA; Burkin DJ; Kaufman SJ; Lamandé SR; North KN
    Neurology; 2008 Jul; 71(5):312-21. PubMed ID: 18160674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. POMT2 mutations cause alpha-dystroglycan hypoglycosylation and Walker-Warburg syndrome.
    van Reeuwijk J; Janssen M; van den Elzen C; Beltran-Valero de Bernabé D; Sabatelli P; Merlini L; Boon M; Scheffer H; Brockington M; Muntoni F; Huynen MA; Verrips A; Walsh CA; Barth PG; Brunner HG; van Bokhoven H
    J Med Genet; 2005 Dec; 42(12):907-12. PubMed ID: 15894594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan.
    Godfrey C; Clement E; Mein R; Brockington M; Smith J; Talim B; Straub V; Robb S; Quinlivan R; Feng L; Jimenez-Mallebrera C; Mercuri E; Manzur AY; Kinali M; Torelli S; Brown SC; Sewry CA; Bushby K; Topaloglu H; North K; Abbs S; Muntoni F
    Brain; 2007 Oct; 130(Pt 10):2725-35. PubMed ID: 17878207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital muscular dystrophies with defective glycosylation of dystroglycan: a population study.
    Mercuri E; Messina S; Bruno C; Mora M; Pegoraro E; Comi GP; D'Amico A; Aiello C; Biancheri R; Berardinelli A; Boffi P; Cassandrini D; Laverda A; Moggio M; Morandi L; Moroni I; Pane M; Pezzani R; Pichiecchio A; Pini A; Minetti C; Mongini T; Mottarelli E; Ricci E; Ruggieri A; Saredi S; Scuderi C; Tessa A; Toscano A; Tortorella G; Trevisan CP; Uggetti C; Vasco G; Santorelli FM; Bertini E
    Neurology; 2009 May; 72(21):1802-9. PubMed ID: 19299310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seizure-genotype relationship in Fukuyama-type congenital muscular dystrophy.
    Yoshioka M; Higuchi Y; Fujii T; Aiba H; Toda T
    Brain Dev; 2008 Jan; 30(1):59-67. PubMed ID: 17597323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic spectrum of Fukutinopathy: most severe phenotype of Fukutinopathy.
    Yoshioka M
    Brain Dev; 2009 Jun; 31(6):419-22. PubMed ID: 18834683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. POMT2 intragenic deletions and splicing abnormalities causing congenital muscular dystrophy with mental retardation.
    Yanagisawa A; Bouchet C; Quijano-Roy S; Vuillaumier-Barrot S; Clarke N; Odent S; Rodriguez D; Romero NB; Osawa M; Endo T; Taratuto AL; Seta N; Guicheney P
    Eur J Med Genet; 2009; 52(4):201-6. PubMed ID: 19138766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Milder phenotype of congenital muscular dystrophy in a novel POMT1 mutation.
    Al-Zaidy SA; Baskin B; Hawkins C; Yoon G; Ray PN; Vajsar J
    Muscle Nerve; 2012 May; 45(5):752-5. PubMed ID: 22499106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy.
    Kanagawa M; Nishimoto A; Chiyonobu T; Takeda S; Miyagoe-Suzuki Y; Wang F; Fujikake N; Taniguchi M; Lu Z; Tachikawa M; Nagai Y; Tashiro F; Miyazaki J; Tajima Y; Takeda S; Endo T; Kobayashi K; Campbell KP; Toda T
    Hum Mol Genet; 2009 Feb; 18(4):621-31. PubMed ID: 19017726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan.
    Brockington M; Blake DJ; Prandini P; Brown SC; Torelli S; Benson MA; Ponting CP; Estournet B; Romero NB; Mercuri E; Voit T; Sewry CA; Guicheney P; Muntoni F
    Am J Hum Genet; 2001 Dec; 69(6):1198-209. PubMed ID: 11592034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fukutin gene retrotransposal insertion in a non-Japanese Fukuyama congenital muscular dystrophy (FCMD) patient.
    Xiong H; Wang S; Kobayashi K; Jiang Y; Wang J; Chang X; Yuan Y; Liu J; Toda T; Fukuyama Y; Wu X
    Am J Med Genet A; 2009 Nov; 149A(11):2403-8. PubMed ID: 19842201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fukutin mutations in non-Japanese patients with congenital muscular dystrophy: less severe mutations predominate in patients with a non-Walker-Warburg phenotype.
    Yis U; Uyanik G; Heck PB; Smitka M; Nobel H; Ebinger F; Dirik E; Feng L; Kurul SH; Brocke K; Unalp A; Özer E; Cakmakci H; Sewry C; Cirak S; Muntoni F; Hehr U; Morris-Rosendahl DJ
    Neuromuscul Disord; 2011 Jan; 21(1):20-30. PubMed ID: 20961758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New FKRP mutations causing congenital muscular dystrophy associated with mental retardation and central nervous system abnormalities. Identification of a founder mutation in Tunisian families.
    Louhichi N; Triki C; Quijano-Roy S; Richard P; Makri S; Méziou M; Estournet B; Mrad S; Romero NB; Ayadi H; Guicheney P; Fakhfakh F
    Neurogenetics; 2004 Feb; 5(1):27-34. PubMed ID: 14652796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep-intronic variant of fukutin is the most prevalent point mutation of Fukuyama congenital muscular dystrophy in Japan.
    Kobayashi K; Kato R; Kondo-Iida E; Taniguchi-Ikeda M; Osawa M; Saito K; Toda T
    J Hum Genet; 2017 Nov; 62(11):945-948. PubMed ID: 28680109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.